The benefits of investigating allogeneic CAR-T products for patients with B-ALL

(1:17)

Investigating allogeneic iNKT cell therapy

(8:28)

Current investigations in the use of allogeneic transplant in the treatment of myeloma

(1:56)

What is an allogeneic transplant? #AML

(1:36)

Allogeneic Stem Cell Transplant Discharge: Leaving the Hospital

(8:51)

Allogeneic Transplant - Late effects of transplant (Part 4)

(1:20:45)

A study investigating the optimal donor type for alloSCT in secondary AML

(2:4)

Allogeneic Ch. 2: Bone marrow and stem cell transplants

(3:22)

CARBON trial: investigating CTX110 allogeneic CRISPR-Cas9–engineered CAR-Ts in R/R LBCL

(1:23)

Allogeneic Transplant

(4:49)

Allogeneic Transplant - Hospitalisation and beyond (Part 2)

(1:7:50)

Allogeneic Transplants with Dr. Hillard M. Lazarus

(55:59)

Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant

(8:29)

Phase II results of WU-CART-007, an allogeneic CAR T-cell targeting CD7, in R/R T-ALL/LBL

(2:17)

What is an Allogeneic Stem Cell Transplant?

(4:32)

Types of stem cell transplants: autologous vs. allogeneic

(1:51)

Allogeneic Stem Cell Transplant: What You Need to Know

(3:23)

Could allogeneic stem cell transplantation be avoided in patients with Ph+ ALL?

(6:28)